News
Pfizer faces challenges from pricing pressures, a 2026 patent cliff, and weak R&D momentum. Click here to find out why I rate ...
Construction work paused at 235 East 42nd Street, David Werner and Metro Loft’s massive office-to-resi conversion in Midtown ...
Looking into the current session, Pfizer Inc. (PFE) shares are trading at $25.84, after a 0.39% increase. Moreover, over the ...
The trend in the state is consistent with an uptick in several parts of the country, including New York and California.
Pigot most recently served as chief commercial officer at Aerovate Therapeutics, which was developing a dry powder inhaled ...
1d
Zacks Investment Research on MSNPfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...
3d
TipRanks on MSNWhy Pfizer’s (PFE) Oncology Gamble is Finally Paying Off
Pfizer ($PFE) may finally be turning the corner on its post-pandemic revenue challenges. The company recently reported ...
The market offers significant opportunities driven by increasing demand for personalized therapies, especially in oncology and rare diseases. Targete ...
The members of Kiruna Church primarily worship in Swedish, their country’s main language. But this Lutheran church some 200 ...
India and China have agreed to explore demarcating their disputed border, a key move toward resolving decades-old territorial disputes as the neighbors look to recalibrate ties against the backdrop of ...
Non-inferiority trial to assess safety and efficacy, including rates of disease rebound and incidence of Long COVID development of ratutrelvir, a ritonavir-free treatment, compared to PAXLOVID® Separa ...
Pfizer is making significant strides in the oncology sector, boasting a robust lineup of cancer treatments. Its oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results